Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 93 clinical trials
A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

The main aim of the study is to check effectiveness of rVWF (vonicog alfa) prophylaxis based on the annualized bleeding rate (ABR) of spontaneous (not related to trauma) bleeding episodes in pediatric and adult participants during the first 12 months on study treatment. The participants will be treated with rVWF …

vonicog alfa
body mass index
Factor VIII
  • 02 May, 2022
  • 29 locations
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

The main aim of the study is to check effectiveness, side effects, and tolerability of recombinant von Willebrand Factor (rVWF), with or without ADVATE, in the treatment and control of nonsurgical bleeding events in pediatric participants (less than (<)18 years of age) with severe hereditary von Willebrand disease (VWD). The …

Factor VIII
von willebrand factor
coagulation studies
  • 15 May, 2022
  • 31 locations
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE)

This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability of belapectin compared with placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis and clinical signs of portal hypertension but without esophageal varices at baseline.

tubal ligation
platelet count
high-density lipoprotein
  • 26 Jul, 2022
  • 128 locations
Gene Therapy for Haemophilia A.

The GO-8 study focuses on assessing safety and efficacy of gene therapy for patients with severe haemophilia A

joint pain
severe haemophilia a
antihemophilic factor
bleeding tendency
  • 24 Jan, 2021
  • 3 locations
A Study of ADVATE in People With Hemophilia A in India

The main aim of this study is to learn more about side effects of Advate when given as standard treatment to people with hemophilia A who have already been treated. The study sponsor will

  • 23 Mar, 2022
  • 5 locations
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

This is a Phase I study. This research study is being conducted to find new ways to treat severe hemophilia A. This study is a gene therapy study. Gene therapy is an experimental way to

renal function
severe haemophilia a
coagulation factor
antihemophilic factor
  • 31 Oct, 2021
  • 1 location
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

, recessive bleeding disorder hemophilia A. The clinical presentation ranges from a mild to severe bleeding phenotype that correlates with the patient's residual plasma FVIII activity level. Current

  • 05 May, 2022
  • 1 location
Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 (270-203)

) based gene therapy vector) in severe Hemophilia A patients with pre-existing antibodies against AAV5.

Factor VIII
  • 10 Mar, 2022
  • 3 locations
Therapeutic Exercise in Patients With Hemophilia (Hemofisio)

hemophilia Design: Quantitative, experimental, longitudinal and prospective study. Subjects: Male patients between 30 and 45 years old, with hemophilia type A or B and with knee, ankle or

  • 29 May, 2022
  • 1 location
A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors.

  • 16 May, 2022
  • 1 location